RECENT ARTICLES

Letter to the Journal: The COVID-19 innovation race, a case study

Personalised Medicine and Disease Modification in Osteoarthritis: On our journey but still a way to go!

Moving Towards Individualized Care for Cardiovascular Disease

Representative Sequencing (RepSeq) for whole tumor samples

Laboratory Testing for SARS-CoV-2: Current Landscape and Lessons Learned

Pulmonary Hypertension: Re-imagining Precision Diagnostics and Therapeutics via microRNA Biology

Golden Helix’s Recent Release for a New Workflow for Interpretating and Reporting Copy Number Variants in Concordance with the Recently Updated ACMG Guidelines: Introduction

Precision Medicine: Dx leads to Rx

Transforming Unstructured Social Media Content to Meaningful Insights: A Three-Prong Strategic Offering to Discover, Engage, and Accelerate Research

Aligning Reimbursement for Digital Pathology with its Value

Diffuse intrinsic pontine glioma (DIPG): A rare childhood brainstem tumor

COVID-19 and Clinical Trials: Past, Present, and Future

Researchers Turn Attention to ‘Practice Gap’ as Studies Show Failure to Align Treatment With Genetic Testing Results

Precision and digital medicine: transforming the patient journey and medical education

How to achieve Precision in the Diagnosis? Executive and clinical lessons out of COVID-19

The COTA Nodal Address Model: A Novel Digital Classification System Identifies Variances in Cancer Care Cost to Support Value Based Care Delivery

Finding ‘The Easy Button’ In Precision Medicine

The Approved RET-Fusion NGS‑based Companion Diagnotic Test for Pralsetinib

LATEST NEWS

Regeneron Reports Fourth Quarter and Full Year 2020 Financial and Operating Results

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has announced financial results for the fourth quarter and full year 2020 and provided a business update. “In 2020,...

Read More

Thermo Fisher Scientific and JW Therapeutics Announce CAR-T Partnership in China

Thermo Fisher Scientific, the world leader in serving science, has signed an agreement with JW Therapeutics, a leading cell therapy company, to ensure non-exclusive...

Read More

Merck KGaA, Darmstadt, Germany, Announces Leadership Change for North America and Global Innovative Medicine Franchises in Healthcare

Merck KGaA, Darmstadt, Germany, which operates its Healthcare business sector as EMD Serono in the US and Canada, today announced that Rehan Verjee has...

Read More

Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year...

Read More

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, announces a collaboration with Gabriel Precision...

Read More

23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics

23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group,...

Read More

Multimedia

 Tweets

  • Precision MedicineI'm hosting Pharmacogenomics & Pharmacovigilance in Precision Medicine. Would you like to attend? ,
  • Precision MedicineI'm hosting Pharmacogenomics & Pharmacovigilance in Precision Medicine. Would you like to attend? ,
  • Precision MedicineDon't miss our first virtual event of 2021! Dr. Howard McLeod, leads off our PGx & Pharmacovigilance Summit. The fi… ,
  • Precision MedicineNew post: Regeneron Reports Fourth Quarter and Full Year 2020 Financial and Operating Results ,

Subscribe now to receive your FREE copy of The Journal of Precision Medicine